FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313200867> ?p ?o ?g. }

• W4313200867 endingPage "184.e9" @default.
• W4313200867 startingPage "184.e1" @default.
• W4313200867 abstract "When using post-transplantation cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis for lymphoma patients, it is currently unknown whether a matched unrelated donor (MUD) or a haploidentical related donor is preferable if both are available. In this study we wanted to test whether using a haploidentical donor has the same results of a MUD. A total of 2140 adults (34% Center for International Blood and Marrow Transplant Research, 66% European Society for Blood and Marrow Transplantation registry) aged ≥18 years who received their first haploidentical hematopoietic cell transplantation (haplo-HCT) or MUD-HCT (8/8 match at HLA-loci A, B, C, and DRB1) for lymphoma using PTCy-based GVHD prophylaxis from 2010 to 2019 were retrospectively analyzed. The majority of both MUD and haploidentical HCTs received reduced intensity/nonmyeloablative conditioning (74% and 77%, respectively) and used a peripheral blood stem cell graft (91% and 60%, respectively) and a 3-drug GVHD prophylaxis (PTCy + calcineurin inhibitor + MMF in 54% and 90%, respectively). Haploidentical HCT has less favorable results versus MUD cohort in terms of overall mortality (hazard ratio [HR= = 1.69; 95% confidence interval [CI], 1.30-2.27; P < .001), progression-free survival (HR=1.39; 95% CI, 1.10-1.79; P = .008), nonrelapse mortality (HR = 1.93; 95% CI, 1.21-3.07; P = .006), platelet engraftment (HR = 0.69; 95% CI, 0.59-0.80; P < .001), acute grade 2-4 GVHD incidence (HR = 1.65; 95% CI, 1.28-2.14; P < .001), and chronic GVHD (HR = 1.79; 95% CI, 1.30-2.48, P < .001). No significant differences were observed in terms of relapse and neutrophil engraftment. Adjusting for propensity score yielded similar results. Whenever MUD is available in a timely manner, it should be preferred over a haploidentical donor when using PTCy-based GVHD prophylaxis for patients with lymphoma." @default.
• W4313200867 created "2023-01-06" @default.
• W4313200867 creator A5001904777 @default.
• W4313200867 creator A5011030256 @default.
• W4313200867 creator A5019858492 @default.
• W4313200867 creator A5021060422 @default.
• W4313200867 creator A5031390636 @default.
• W4313200867 creator A5034694882 @default.
• W4313200867 creator A5035799376 @default.
• W4313200867 creator A5039235274 @default.
• W4313200867 creator A5043585238 @default.
• W4313200867 creator A5050581544 @default.
• W4313200867 creator A5052064208 @default.
• W4313200867 creator A5052684200 @default.
• W4313200867 creator A5055226769 @default.
• W4313200867 creator A5056416633 @default.
• W4313200867 creator A5058571002 @default.
• W4313200867 creator A5064818358 @default.
• W4313200867 creator A5066352955 @default.
• W4313200867 creator A5066698925 @default.
• W4313200867 creator A5070378721 @default.
• W4313200867 creator A5072936036 @default.
• W4313200867 creator A5083379505 @default.
• W4313200867 creator A5085142676 @default.
• W4313200867 creator A5085146093 @default.
• W4313200867 date "2023-03-01" @default.
• W4313200867 modified "2023-10-18" @default.
• W4313200867 title "Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas" @default.
• W4313200867 cites W1977455450 @default.
• W4313200867 cites W1978164777 @default.
• W4313200867 cites W2039334806 @default.
• W4313200867 cites W2075009488 @default.
• W4313200867 cites W2089998734 @default.
• W4313200867 cites W2091661505 @default.
• W4313200867 cites W2116483603 @default.
• W4313200867 cites W2119147717 @default.
• W4313200867 cites W2126021331 @default.
• W4313200867 cites W2152197116 @default.
• W4313200867 cites W2307073326 @default.
• W4313200867 cites W2598700764 @default.
• W4313200867 cites W2681369214 @default.
• W4313200867 cites W2800808649 @default.
• W4313200867 cites W2808115506 @default.
• W4313200867 cites W2886922441 @default.
• W4313200867 cites W2945827479 @default.
• W4313200867 cites W2961599785 @default.
• W4313200867 cites W2978299062 @default.
• W4313200867 cites W2981006638 @default.
• W4313200867 cites W3004048045 @default.
• W4313200867 cites W3064523218 @default.
• W4313200867 cites W3155027991 @default.
• W4313200867 cites W3159907345 @default.
• W4313200867 cites W3195081024 @default.
• W4313200867 cites W3217075939 @default.
• W4313200867 cites W4220903742 @default.
• W4313200867 cites W4281647571 @default.
• W4313200867 doi "https://doi.org/10.1016/j.jtct.2022.11.028" @default.
• W4313200867 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36577482" @default.
• W4313200867 hasPublicationYear "2023" @default.
• W4313200867 type Work @default.
• W4313200867 citedByCount "0" @default.
• W4313200867 crossrefType "journal-article" @default.
• W4313200867 hasAuthorship W4313200867A5001904777 @default.
• W4313200867 hasAuthorship W4313200867A5011030256 @default.
• W4313200867 hasAuthorship W4313200867A5019858492 @default.
• W4313200867 hasAuthorship W4313200867A5021060422 @default.
• W4313200867 hasAuthorship W4313200867A5031390636 @default.
• W4313200867 hasAuthorship W4313200867A5034694882 @default.
• W4313200867 hasAuthorship W4313200867A5035799376 @default.
• W4313200867 hasAuthorship W4313200867A5039235274 @default.
• W4313200867 hasAuthorship W4313200867A5043585238 @default.
• W4313200867 hasAuthorship W4313200867A5050581544 @default.
• W4313200867 hasAuthorship W4313200867A5052064208 @default.
• W4313200867 hasAuthorship W4313200867A5052684200 @default.
• W4313200867 hasAuthorship W4313200867A5055226769 @default.
• W4313200867 hasAuthorship W4313200867A5056416633 @default.
• W4313200867 hasAuthorship W4313200867A5058571002 @default.
• W4313200867 hasAuthorship W4313200867A5064818358 @default.
• W4313200867 hasAuthorship W4313200867A5066352955 @default.
• W4313200867 hasAuthorship W4313200867A5066698925 @default.
• W4313200867 hasAuthorship W4313200867A5070378721 @default.
• W4313200867 hasAuthorship W4313200867A5072936036 @default.
• W4313200867 hasAuthorship W4313200867A5083379505 @default.
• W4313200867 hasAuthorship W4313200867A5085142676 @default.
• W4313200867 hasAuthorship W4313200867A5085146093 @default.
• W4313200867 hasConcept C120665830 @default.
• W4313200867 hasConcept C121332964 @default.
• W4313200867 hasConcept C126322002 @default.
• W4313200867 hasConcept C128057223 @default.
• W4313200867 hasConcept C141071460 @default.
• W4313200867 hasConcept C207103383 @default.
• W4313200867 hasConcept C2776694085 @default.
• W4313200867 hasConcept C2776755627 @default.
• W4313200867 hasConcept C2777408962 @default.
• W4313200867 hasConcept C2779338263 @default.
• W4313200867 hasConcept C2779972918 @default.
• W4313200867 hasConcept C2911091166 @default.
• W4313200867 hasConcept C44249647 @default.

• next